APA (7th ed.) Citation

Jarne-Ferrer, J., Griñán-Ferré, C., Jora, B., Codony, S., Miró, L., Rosell-Cardona, C., . . . Pallàs, M. (2026). Soluble Epoxide Hydrolase Inhibition Improves Alzheimer's Disease Hallmarks: Correlation with Peripheral Inflammation and Gut Microbiota Modulation. Aging & Disease, 17(2), 1131. https://doi.org/10.14336/AD.2025.0201

Chicago Style (17th ed.) Citation

Jarne-Ferrer, Júlia, et al. "Soluble Epoxide Hydrolase Inhibition Improves Alzheimer's Disease Hallmarks: Correlation with Peripheral Inflammation and Gut Microbiota Modulation." Aging & Disease 17, no. 2 (2026): 1131. https://doi.org/10.14336/AD.2025.0201.

MLA (9th ed.) Citation

Jarne-Ferrer, Júlia, et al. "Soluble Epoxide Hydrolase Inhibition Improves Alzheimer's Disease Hallmarks: Correlation with Peripheral Inflammation and Gut Microbiota Modulation." Aging & Disease, vol. 17, no. 2, 2026, p. 1131, https://doi.org/10.14336/AD.2025.0201.